Glioma subtype, 1p/19q co-deletion, grade II gliomas, IDH mutational status, and MGMT methylation were associated with lower-risk scores in TCGA and the two CGGA databases (p < 0.001; Supplementary Figure S6). This evidence concerns the gene MGMT and central nervous system cancer.